Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL cer... ( SAN DIEGO July 14 /- Cardium Ther...)

HOME >> BIOLOGY >> TECHNOLOGY

Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification

Date:7/14/2008

SAN DIEGO, July 14 /PRNewswire-FirstCall/ -- Cardium Therapeutics (Amex: CXM) and its operating unit InnerCool Therapies, Inc., announced today that InnerCool's RapidBlue(TM) endovascular temperature modulation system conforms to the European Union CE Mark requirements for use in inducing, maintaining and reversing mild hypothermia in a variety of clinical indications including cardiac arrest, neurosurgery, fever, cardiovascular re-warming, trauma re-warming, and potential additional applications including acute ischemic stroke and myocardial infarction (heart attack). The CE Mark will allow the Company to begin marketing the RapidBlue system in Europe and many other countries that recognize the certification. The Company expects to begin selling the RapidBlue System through its established distribution network next quarter. As previously reported, InnerCool's RapidBlue System is currently under review for FDA 510(k) clearance.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080714/LAM033)

(Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

"We believe our RapidBlue System is truly the most dynamic and best-in-class temperature modulation system on the market and receiving CE Mark and UL certification demonstrates that the Company has established and operates a world class quality system. Based on our three year development effort, InnerCool's RapidBlue System establishes new performance standards by which all other endovascular and surface systems on a worldwide basis will now be judged," stated Christopher J. Reinhard, Chairman and Chief Execut
'/>"/>

SOURCE Cardium Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. Cardium Announces Follow-On Direct Investment by Institutional Investor
2. Cardium Selected for Inclusion in Russell Microcap Index
3. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
4. Cardium Launches New AWARE Clinical Study Website
5. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
6. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
9. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
10. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
11. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion

Post Your Comments:

(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personali... to take place on February 22-24, 2010 in Philadel...ence we will highlight key issues in forming partn...r experiences. , Minneapo... Arrowhead’s 2010 Personalized Medicine Par...

(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...

(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...

(Date:11/5/2009)...vember 5, 2009 Senomyx, ...proprietary taste receptor-based technologies to d...erage, and ingredient supply industries, today pro...sults for the third quarter ended September 30, 20...ter of 2009, compared to $4.0 million for the thir...

[0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix [0] Transgenomic, Inc. Reports Third Quarter 2009 Results [0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS

...ETHESDA, Md., Feb. 29 Micromet, Inc.,(Nasdaq: MI..., proprietary,antibodies for the treatment of canc...nounced that Dr. Christian Itin, President and Chi...the Susquehanna Financial,Group,s SIGnificant Inve..., at 10:30 am ET at the W Hotel in New York., Dr....

...UEBEC CITY, Feb. 29 /PRNewswire-FirstCall/ - AEter...bal biopharmaceutical company focused on,endocrine...tion of Mario,Paradis, CA, the Company,s Senior Vi...orporate Secretary. Mr. Paradis has accepted the p...cer of Atrium Innovations, a leading,developer, ma...

...RVINE, Calif., Feb. 29 NuRx Pharmaceuticals,Inc. ...retained Russo,Partners LLC for the provision of i...nsel., The healthcare communications firm will im...nvestor targeting, the scheduling of,presentations...r corporate,visibility initiatives. Russo Partners...

Other Biology Technology:Micromet to Present at the Susquehanna Financial Group's SIGnificant Investment Options Conference on March 4, 2008 2 AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs 2 NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel 2 NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel 3

Micromet to Present at the Susquehanna Financial Group's SIGnificant Investment Options Conference on March 4, 2008 AEterna Zentaris Announces the Departure of SVP, Administrative and Legal Affairs NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel

(Date:11/4/2009)...deciphered the DNA codes, or genomes, of the famed...ed The Genome 10K Project, an international effort...s on 10,000 species of animals for conducting comp...be achieved. , Participating in The Genome 10K p... 5, 2009 issue of the Journal of Heredity , are 7...

(Date:11/4/2009)...Newswire-FirstCall/ -- Quest Diagnostics Incorpora... diagnostic testing, information and services, ann...30, 2009, income from continuing operations rose t...160 million, or $0.81 per diluted share, for the t...ts were reduced by a $0.03 per share charge associ...

(Date:11/4/2009)...wswire/ -- What,s the cost of saving a teenage lif...sulting from prescription medication abuse, there,...ver, may be unaware that the lock-boxes they,ve in...cking timebomb of prescription drugs. That,s why M...dical supplies, has formed an exclusive partnershi...

[0] Singapore scientists join international study of 10,000 vertebrates' genomes [0] Quest Diagnostics Reports Strong Performance in Third Quarter 2009 [0] MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse

...008 Two new articles examine the theory of "fetal...sparities. The studies, published in American Jou...tes of hypertension and cardiovascular disease pre...low birth weights, and that these low birth weight...ctors. , It is well-established that the nutritio...

...e sang with the croaks, chirps and ribbits of doze...ms of a fungus that,s decimating amphibian populat... been documented for more than a decade, but until...s of frogs alters the larger ecosystem. A Universi...sively examine an ecosystem before and after an am...

...ssouri Department of Psychological Sciences introd...he opening of the Brain Imaging Center (BIC). The ...l research on diseases that can have tremendous im...ophrenia and other neurocognitive disorders using ...he Brain Imaging Center is a state-of-the-art neur...

Other Biology News:Racial disparities in cardiovascular health linked to birth weight, slavery 2 Racial disparities in cardiovascular health linked to birth weight, slavery 3 UGA study reveals ecosystem-level consequences of frog extinctions 2 UGA study reveals ecosystem-level consequences of frog extinctions 3 MU brain imaging center provides research for autism, schizophrenia and Parkinson's disease 2

Racial disparities in cardiovascular health linked to birth weight, slavery UGA study reveals ecosystem-level consequences of frog extinctions MU brain imaging center provides research for autism, schizophrenia and Parkinson's disease

Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience

Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam

Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies

Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam

Biology Products:

Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam

Cardium Announces InnerCool's New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL cer...( SAN DIEGO July 14 /- Cardium Ther...)